STOCK TITAN

Adage Capital discloses 700,000-share position in Forte Biosciences (FBRX) in ownership filing

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Adage Capital Management, L.P. and related parties report their ownership in Forte Biosciences, Inc. common stock. Adage Capital Partners, L.P. directly holds 700,000 shares of Forte Biosciences, Inc. (Common Stock, par value $0.001, CUSIP 34962G208).

This position represents 3.42% of the outstanding common stock, based on 20,478,817 shares outstanding as of May 6, 2026, as reported by the company for the quarter ended March 31, 2026. Adage Capital Management, L.P., and individuals Robert Atchinson and Phillip Gross share voting and dispositive power over these 700,000 shares, with no sole voting or dispositive power reported.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 700,000 shares Common Stock of Forte Biosciences, Inc. held by Adage Capital Partners, L.P.
Ownership percentage 3.42% Portion of Forte Biosciences common stock beneficially owned by the reporting persons
Shares outstanding 20,478,817 shares Forte Biosciences common stock outstanding as of May 6, 2026
Shared voting power 700,000.00 shares Shares over which each reporting person has shared voting power
Shared dispositive power 700,000.00 shares Shares over which each reporting person has shared dispositive power
beneficial ownership financial
"The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
dispositive power financial
"Shared Dispositive Power 700,000.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
percent of class financial
"Percent of class: 3.42%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
investment manager financial
"Adage Capital Management, L.P., a Delaware limited partnership ("ACM"), as the investment manager of Adage Capital Partners, L.P."
limited partnership financial
"Adage Capital Management, L.P., a Delaware limited partnership ("ACM")"
A limited partnership is a legal business structure with two types of partners: at least one general partner who runs the business and bears full legal responsibility, and one or more limited partners who contribute money, share profits, and have liability capped at their investment. For investors, it matters because it separates control from financial exposure — like putting money into a store without managing it — and affects how returns, risks, taxes and transferability of ownership are handled.

FAQ

What percentage of Forte Biosciences (FBRX) does Adage Capital own?

Adage Capital and related reporting persons beneficially own 3.42% of Forte Biosciences’ common stock, representing 700,000 shares out of 20,478,817 shares outstanding as of May 6, 2026, per the company’s Form 10-Q.

How many Forte Biosciences (FBRX) shares are reported by Adage Capital?

Adage Capital Partners, L.P. directly holds 700,000 shares of Forte Biosciences common stock. This stake is managed by Adage Capital Management, L.P., with shared voting and dispositive power reported by Robert Atchinson and Phillip Gross.

Is Adage Capital a 5% or greater shareholder of Forte Biosciences (FBRX)?

No. The reporting group states beneficial ownership of 3.42% of Forte Biosciences’ common stock, which is 5 percent or less of the class, as calculated from 20,478,817 shares outstanding as of May 6, 2026.

Who are the reporting persons in the Forte Biosciences (FBRX) Schedule 13G/A?

The reporting persons are Adage Capital Management, L.P., and individuals Robert Atchinson and Phillip Gross. Adage Capital Partners, L.P. directly holds the shares, with the reporting persons having shared voting and dispositive power over the 700,000 shares.

What is the share count used to calculate Adage’s 3.42% stake in Forte Biosciences (FBRX)?

The 3.42% ownership is calculated using 20,478,817 shares of Forte Biosciences common stock outstanding as of May 6, 2026, as disclosed in the company’s Quarterly Report for the period ended March 31, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





34962G208

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Adage Capital Management, L.P.
Signature:/s/ Robert Atchinson
Name/Title:By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Date:08/12/2026
Robert Atchinson
Signature:/s/ Robert Atchinson
Name/Title:Robert Atchinson, individually
Date:08/12/2026
Phillip Gross
Signature:/s/ Phillip Gross
Name/Title:Phillip Gross, individually
Date:08/12/2026